SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-136711
Filing Date
2022-05-02
Accepted
2022-05-02 16:01:55
Documents
5
Period of Report
2022-06-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d236526ddef14a.htm DEF 14A 375838
2 GRAPHIC g236526g00m09.jpg GRAPHIC 179585
3 GRAPHIC g236526g00m10.jpg GRAPHIC 102179
4 GRAPHIC g236526g02a05.jpg GRAPHIC 32725
5 GRAPHIC g236526g03a22.jpg GRAPHIC 23402
  Complete submission text file 0001193125-22-136711.txt   827658
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38541 | Film No.: 22881813
SIC: 2834 Pharmaceutical Preparations